Positron raises $2M to scale compact PET-CT systems for cardiac imaging

What's the deal? Positron Corporation has raised $2 million to accelerate the commercial rollout of its PET-CT imaging system. The US-based company develops compact positron emission tomography technology aimed at cardiac and outpatient imaging centres that want lower-cost, lower-footprint scanners.

The funding will support manufacturing scale-up, regulatory progress, and early customer deployments. Positron says demand is growing from clinics looking to expand advanced imaging without the cost and space needs of hospital-grade systems.

Why now? Cardiac imaging volumes are rising as cardiovascular disease remains a leading cause of death, while providers face pressure to cut costs and improve access. PET imaging offers higher image quality and lower radiation than older nuclear methods, but adoption has been slowed by price and infrastructure needs.

Smaller, more affordable systems could widen use beyond large hospitals. Positron is betting that timing and technology are aligning.

What could go wrong? Medical imaging is capital intensive and highly regulated, which can slow sales and strain cash. Competing against large, well-funded imaging firms will require proof that Positron’s systems can deliver reliability, service, and clinical outcomes at scale.

Adoption also depends on reimbursement and workflow changes. Clinics may hesitate to invest if payment models or utilisation fall short.

The signal: The raise points to renewed interest in specialised medtech that improves efficiency rather than chasing breakthrough science alone. Investors are backing focused tools that fit outpatient settings and address cost pressure in healthcare.

It also reflects a broader shift toward decentralising advanced diagnostics, bringing hospital-grade capabilities closer to patients through smaller, purpose-built systems.

Sources:
Cardiovascular Business
Applied Radiology
Yahoo! Finance

A.M.